Summary
The Korean company launched a red/near-infrared light therapy device that is worn on the penis for 15 minutes a day to improve erection stiffness and increase testosterone levels. They plan to sell it as a healthcare device, not a medical device. It has been conducting continuous research with Korean university hospital doctors, and has domestic and international patents and CE certification related to the product. They are finding partners (investment or distribution) to enter European market.
Description
The company produces urology and orthopedic healthcare products in collaboration with doctors at university hospitals in Korea. KAISAR, a home care device for men, is a health care device that aims to increase sperm motility, erectile stiffness, and testosterone levels by irradiating light to the male penis and testicles for 15 minutes a day.
The principle of the product is as follows. When a cell is irradiated with a light source of a specific wavelength (635 nm / 850 nm), the main mechanism is to activate cell regeneration through an increase in ATP production in the mitochondria of the cell. In addition, ion channels in the cell respond to the corresponding wavelength, Nitric Oxide , Ca2+, ROS, etc. are increased. There are domestic and foreign papers that improve sperm activity by 20-30% through increased ATP production, and similar results were obtained in their study. Nitric Oxide is an essential substance for erection. In the case of Viagra, it suppresses substances that inhibit NO production and induces good erection. In its product, NO production is directly increased through light irradiation. Through this, erectile stiffness is improved. (There are various research results, and in general, 20% to 100% improvement in stiffness is expected when used for 2 weeks to 2 months. Even in the case of testosterone increase, Leydig cells in the testis Testosterone is produced, and through light irradiation, activation of Leydig cells is induced and production of male hormones is increased.Photobiomodulation research has been published up to about 7,000 papers to date, and papers related to male sexual health are increasing recently. They are conducting joint research with doctors at university hospitals in Korea and continuously accumulating research results.There are many domestic and foreign patents related to the product, and They have obtained FCC and CE certification.
They are discussing with several European companies to enter the European market, and although it has not been confirmed, there is one company that is discussing on the premise of exclusive sales rights for Germany, Switzerland and Austria. In order to enter the European market, they hope to find buyers and investors in Europe, and various business cooperation is possible, such as distributors and exclusive rights for each country in Europe. Product research results and design resources can be shared.